LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy-Reference-Cited by-同舟云学术

LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy

Published:2021-03 Issue: Volume:597 Page:120346
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

d'Avanzo Nicola,Torrieri Giulia,Figueiredo Patrícia,Celia Christian^ORCID,Paolino Donatella,Correia Alexandra,Moslova Karina,Teesalu Tambet,Fresta Massimo,Santos Hélder A.

Funder

Estonian Research Council

Sigrid Jusélius Foundation

European Regional Development Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference133 articles.

1. Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32;Agemy;Mol. Ther.,2013

2. Awareness and current knowledge of breast cancer;Akram;Biol. Res.,2017

3. Metastatic and triple-negative breast cancer: challenges and treatment options;Al-Mahmood;Drug Deliv. Transl. Res.,2018

4. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect;Almeida;Nanomedicine,2017

5. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors;Almeida;Nanoscale,2014

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells;Heliyon;2024-09

2. Precision arrows: Navigating breast cancer with nanotechnology siRNA;International Journal of Pharmaceutics;2024-09

3. Preparation and characterization of nano-emulsion formulations of Asparagus densiflorus root and aerial parts extracts: evaluation of in-vitro antibacterial and anticancer activities of nano-emulsion versus pure plant extract;Drug Development and Industrial Pharmacy;2024-07-02

4. A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer;Drug Delivery and Translational Research;2024-06-17

5. Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models;Coordination Chemistry Reviews;2024-06